$PFE

Value Investing with Sven Carlin, Ph.D. on $PFE (Nov 17, 2026)

AI summary · Value Investing with Sven Carlin, Ph.D.

Pfizer, a 4% portfolio position, has security in its traditional business and scale, which should generate value over time; recent earnings are good and buybacks have resumed. Profits could reverse the decline behind the collapse, leaving a value-level, single-digit P/E, and over time PFE is expected to perform well. Reaching $10 EPS in 2028, or half that goal, at 12x would be a really good return; this is buying actual earnings, not past expectations.

BullishHe framed it in years
“3 Stocks I Own - Research Platform Overview!”
Value Investing with Sven Carlin, Ph.D.Published Nov 17 · 1 passage

Playing via YouTube may share device and playback data and use cookies. Privacy Notice · Google Privacy Policy

Jump to any passage

1 passage

Pfizer, we have started opening an investment center in it. It represents 4% of the portfolio, and I believe there is security in its traditional business, in the core links , the banks, everything, and the scale of the business there that should generate value over time.

There is always the possibility of a reversal of the profits that led to the stock's collapse, bringing it down to a value level and single-digit price-to-earnings ratios . Over time, it is expected to perform well.

They have returned to buyback operations , and recent earnings have been good. And if they manage to achieve their goal, or even half of it, let's say they reach $10 earnings per share in 2028 multiplied by 12, that's a really good return.

You're buying actual earnings , not past expectations that caused the stock to crash, but actual earnings.

Watchpoints

Pfizer reaching $10 in earnings per share in 2028, or half of that goal
TickerSays